Have a personal or library account? Click to login
Comparative Efficacy, Safety and Tolerability of Olanzapine and Blonanserin in Patients with Schizophrenia: A Parallel Group Study Cover

Comparative Efficacy, Safety and Tolerability of Olanzapine and Blonanserin in Patients with Schizophrenia: A Parallel Group Study

Acta Medica Bulgarica
Volume 48 (2021): Issue 2 (July 2021)
By: S. Chattopadhyay,  U. Roy,  S. Biswas,  P. Roy and  P. Mandal  
Open Access
|Aug 2021

Authors

S. Chattopadhyay

Department of Pharmacology, Burdwan Medical College and Hospital, India

U. Roy

uroy951@gmail.com

Department of Pharmacology, Raiganj Govt. Medical College and Hospital, India

S. Biswas

Department of Pharmacology, Burdwan Medical College and Hospital, India

P. Roy

Department of Psychiatry, Burdwan Medical College and Hospital, India

P. Mandal

Department of Pharmacology, Raiganj Govt. Medical College and Hospital, India
DOI: https://doi.org/10.2478/amb-2021-0023 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Journal RSS Feed
Language: English
Page range: 45 - 52
Submitted on: Aug 11, 2020
Accepted on: Sep 29, 2020
Published on: Aug 11, 2021
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
blonanserin,
efficacy,
olanzapine,
safety,
schizophrenia,
tolerability
Related subjects:
Medicine,
Basic medical science,
Immunology,
Clinical medicine,
Clinical medicine, other

© 2021 S. Chattopadhyay, U. Roy, S. Biswas, P. Roy, P. Mandal, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 48 (2021): Issue 2 (July 2021)Next article